Multicancer Screening Global Market Report 2023: Robust Pipeline of Multicancer Screening Tests Poised to Revolutionize Cancer Diagnosis
08 juin 2023 04h08 HE
|
Research and Markets
Dublin, June 08, 2023 (GLOBE NEWSWIRE) -- The "Multicancer Screening Market - A Global and Regional Analysis: Focus on Test Type, Technology, Sample, Method, Cancer Type, Application, End User, and...
Global Cancer Diagnostics Partnering Analysis Report 2023: Key Insight into Terms Included in a Cancer Diagnostics Partnering Agreement, with Real World Examples
06 juin 2023 03h58 HE
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Diagnostics Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.com's offering.The Global Cancer...
Global Diagnostic Specialty Antibodies Market Report 2023: Detection of Malignancy, Autoimmune Disorders, Infectious Illnesses and Pregnancy Bolsters Growth
26 mai 2023 06h58 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Diagnostic Specialty Antibodies Market by Type, Application, and End User and by Region - Global Forecast to 2023-2033" report has been added to ...
Precipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology
22 mai 2023 11h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 22, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a...
Next Generation Cancer Diagnostics Technologies and Global Markets to 2027: Increasing Number of Cancer Cases Drives Growth
10 mai 2023 04h33 HE
|
Research and Markets
Dublin, May 10, 2023 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The base year for...
Colorectal Cancer Diagnostics Market Research Report 2023: Rising Consumer Acceptance of Advanced Therapies Such as Stivarga (regorafenib), Erbitux (cetuximab), & Avastin (bevacizumab) Bolsters Growth
04 mai 2023 07h28 HE
|
Research and Markets
Dublin, May 04, 2023 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type, By...
Global Kidney Cancer Diagnostics Market to Flourish at a 7% CAGR By 2032; Immunohistochemistry-based Diagnostics to Comprise 65% of Total Usage | Fact.MR
03 mai 2023 10h00 HE
|
FACT.MR
Rockville, May 03, 2023 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: During the forecast period 2022-2032, the kidney cancer diagnostics market is expected...
Prostate Cancer Diagnostics Market Report 2023: Growing Need Need for Preventative and Curative Healthcare Presents Opportunities
18 avr. 2023 04h23 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Prostate Cancer Diagnostics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Cancer Diagnostics Market to Reach USD 300.79 Billion by 2031 | Latest InsightAce Study
17 avr. 2023 10h42 HE
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Cancer Diagnostics Market is estimated to reach over USD 300.79 billion by 2031, exhibiting a CAGR of 7.16% during the forecast...
Pet Cancer Therapeutics Market is expected to be valued at US$ 1052.80 Billion by 2033, at 10% CAGR | Future Market Insights, Inc.
07 avr. 2023 04h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, April 07, 2023 (GLOBE NEWSWIRE) -- The global pet cancer therapeutics market size is set to reach US$ 405.90 billion in 2023. Overall sales of cancer therapeutics are likely to surge at...